Skip to main content
. 2019 Jul 11;127(2):444–456. doi: 10.1152/japplphysiol.00587.2018

Fig. 8.

Fig. 8.

Transfusion of CXC chemokine receptor (CXCR) 1/2-rat-induced pluripotent stem cell (iPS)-derived endothelial cells (ECs) or CC chemokine receptor (CCR) 2/5-iPS-ECs attenuate lipopolysaccharide (LPS)-induced lung edema (A) and microvascular permeability (B) at 6 h after LPS treatment. Results are means ± SE; n = 6–8 rats/group. P < 0.05 versus respective sham control groups (*), versus respective LPS + vehicle groups (†), and versus respective LPS + AdNull-iPS-ECs groups (‡). One-way ANOVA was used to analyze the data, followed by a multiple-comparison Tukey’s post hoc test.